85361-4

HIV 1+2 RNA [Presence] in Blood by NAA with probe detection

Active

Term Description

This term is used for assays that can detect, but not differentiate between, HIV-1 and HIV-2 RNA. This term was created for, but is not limited in use to, the submitter's cobas HIV-1/HIV-2 qualitative assay.
Source: Regenstrief LOINC

Part Description

LP16715-2 HIV 1+2
Two types of human immunodeficiency viruses (HIV) have been characterized: HIV-1 and HIV-2. HIV-1 was initially discovered in the early 1980s and thought to be the sole causative agent of HIV infections and ultimately AIDS. In 1986, HIV-2 was isolated and also found to cause AIDs. HIV-1 is more virulent and the predominant cause of the HIV infections worldwide. HIV-2 is poorly transmitted and is primarily concentrated in West Africa.

Presently (2012), HIV-1 strains are divided into four groups, including group M (major) with subtypes A through K, group O (outlier), group N (non-M or O), and group P. HIV-2 is divided into subtypes A through E. Occasionally, two viruses of different subtypes can "cross react" and blend their genetic material to create a new hybrid HIV virus. However, many of these new strains do not survive for long. Studies have also shown that the core proteins of HIV-1 and HIV-2 display frequent cross-reactivity whereas the envelope proteins are more type-specific. Source: Regenstrief LOINC

Fully-Specified Name

Component: HIV 1+2 RNA
Property: PrThr
Time: Pt
System: Bld
Scale: Ord
Method: Probe.amp.tar

Additional Names

Short Name: HIV1+2 RNA Bld Ql NAA+probe
Display Name: HIV 1+2 RNA NAA+probe Ql (Bld)
Consumer Name Alpha Get Info: HIV 1+2, Blood

Example Answer List: LL2888-7

Source: Roche Diagnostics International

Answer	Code	Score	Answer ID
NonreactiveCopyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value)			LA15256-3
ReactiveCopyright http://snomed.info/sct ID:11214006 Reactive (qualifier value)			LA15255-5
InvalidCopyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value)			LA15841-2

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.61
Last Updated: Version 2.63
Order vs. Observation: Both

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	HIV-1+2 RNA:Nachweis oder Schwellenwert:Zeitpunkt:Blut:Ordinal:Zielfragmentamplifikation mit Sondendetektion
el-GR	Greek (Greece)	HIV 1+2 RNA:PrThr:Χρονική στιγμή:Αίμα:Τακτική:Ανιχνευτής με ενίσχυση στόχου
es-ES	Spanish (Spain)	VIH 1-2 RNA:PrThr:Punto temporal:Sangre:Ord:Sonda con amplificación dirigida
es-MX	Spanish (Mexico)	ARN del VIH 1 + 2:Presencia o umbral:Punto temporal:Sangre:Ordinal:Amplificación de ácidos nucleicos con detección de sonda
fr-CA	French (Canada)	VIH 1+2 , ARN:Présence-Seuil:Temps ponctuel:Sang:Ordinal:Sonde avec amplification de la cible
fr-FR	French (France)	VIH-1+2 ARN:Présence/Seuil:Ponctuel:Sang:Qualitatif:PCR amplification de cible
fr-BE	French (Belgium)	VIH 1+2 ARN:PrThr:Temps ponctuel:Sang:Ordinal:Sonde avec amplification de la cible Synonyms: HIV HIV 1 HIV 1&2 HIV 1+2
it-IT	Italian (Italy)	HIV 1+2 RNA:PrThr:Pt:Sangue:Ord:Sonda.amp.tar Synonyms: Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NL	Dutch (Netherlands)	HIV 1+2 RNA:aanwezigheid:moment:bloed:ordinaal:probe-detectie Synonyms: probe.amp.tar
ru-RU	Russian (Russian Federation)	HIV 1+2 РНК:PrThr:ТчкВрм:Кр:Пор:Проба.усил.миш Synonyms: ВИЧ ВИЧ 1 ВИЧ 1 и 2 ВИЧ 1+2 ДНК проба;ДНК зонд Кровь Порядковый Проба с мишени усилением Точка во времени;Момент
tr-TR	Turkish (Turkey)	HIV 1+2 RNA:MevcEşik:Zmlı:Kan:Srl:Prob.amf.hdf Synonyms: Mevcut
zh-CN	Chinese (China)	HIV 1 型+2 型 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向 Synonyms: Ⅰ Ⅱ AIDS;AIDS 病毒;人类免疫缺陷病毒;人类免疫缺陷病毒（Human immunodeficiency virus，HIV）;爱滋病;艾滋病;艾滋病病毒;获得性免疫缺陷综合征;获得性免疫缺陷综合征（Acquired Immure Deficiency Syndrome，AIDS，艾滋病） HIV1;HTLV 3;HTLV III;人类免疫缺陷病毒 1 型;人类免疫缺陷病毒 I 型;HIV 1 型（人类免疫缺陷病毒 1 型、人类免疫缺陷病毒 I 型、人免疫缺陷病毒 1 型、人免疫缺陷病毒 I 型、HIV I、HIV I 型、艾滋病病毒 I 型） I II 人类免疫缺陷病毒 1 与 2 型;HIV（人类免疫缺陷病毒、人免疫缺陷病毒、艾滋病病毒） 1 型（I 型）与 2 型（II 型）人类免疫缺陷病毒 1+2 型;HIV 1+2 型（人类免疫缺陷病毒 1+2 型、人类免疫缺陷病毒 I+II 型、人免疫缺陷病毒 1+2 型、人免疫缺陷病毒 I+II 型、HIV I+II、HIV I+II 型、艾滋病病毒 I+II 型）依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型借助扩增的探针方法;借助扩增的探针法;探针法.扩增借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）扩增型扩增性时刻;随机;随意;瞬间核糖核酸;Ribonucleic acid 经过扩增的脱氧核糖核酸探针血;血液

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=85361-4

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.